MRRS adds "Graves’ Ophthalmopathy – Pipeline Review, H2 2016" latest studies, published in December 2016. It is a professional and in-depth study.

Summary
Global Markets Direct’s latest Pharmaceutical and Healthcare disease pipeline guide Graves’ Ophthalmopathy – Pipeline Review, H2 2016, provides an overview of the Graves’ Ophthalmopathy (Ophthalmology) pipeline landscape.

Graves’ ophthalmopathy is an autoimmune condition where the thyroid gland mistakenly senses harmful cells and releases antibodies to combat them. Since there are no harmful cells, the released antibodies end up fusing with muscles in the eyes, causing the onset of Graves‘ophthalmopathy. Symptoms include eye redness, eye inflammation, eyelid retraction and eye weakness. Treatment includes radioiodine therapy, anti-thyroid medications and thyroid surgery.

Scope
– The pipeline guide provides a snapshot of the global therapeutic landscape of Graves’ Ophthalmopathy (Ophthalmology).
– The pipeline guide reviews pipeline therapeutics for Graves’ Ophthalmopathy (Ophthalmology) by companies and universities/research institutes based on information derived from company and industry-specific sources.
– The pipeline guide covers pipeline products based on several stages of development ranging from pre-registration till discovery and undisclosed stages.
– The pipeline guide features descriptive drug profiles for the pipeline products which comprise, product description, descriptive licensing and collaboration details, R&D brief, MoA & other developmental activities.
– The pipeline guide reviews key companies involved in Graves’ Ophthalmopathy (Ophthalmology) therapeutics and enlists all their major and minor projects.
– The pipeline guide evaluates Graves’ Ophthalmopathy (Ophthalmology) therapeutics based on mechanism of action (MoA), drug target, route of administration (RoA) and molecule type.
– The pipeline guide encapsulates all the dormant and discontinued pipeline projects.
– The pipeline guide reviews latest news related to pipeline therapeutics for Graves’ Ophthalmopathy (Ophthalmology)

Table Of Contents
Table of Contents 2
List of Tables 4
List of Figures 4
Introduction 5
Global Markets Direct Report Coverage 5
Graves' Ophthalmopathy Overview 6
Therapeutics Development 7
Pipeline Products for Graves' Ophthalmopathy - Overview 7
Graves' Ophthalmopathy - Therapeutics under Development by Companies 8
Graves' Ophthalmopathy - Pipeline Products Glance 9
Clinical Stage Products 9
Early Stage Products 10
Graves' Ophthalmopathy - Products under Development by Companies 11
Graves' Ophthalmopathy - Companies Involved in Therapeutics Development 12
Genmab A/S 12
Neothetics Inc 13
Novartis AG 14
Yuhan Corp 15
Graves' Ophthalmopathy - Therapeutics Assessment 16
Assessment by Monotherapy Products 16
Assessment by Combination Products 17
Assessment by Target 18
Assessment by Mechanism of Action 20
Assessment by Route of Administration 22
Assessment by Molecule Type 24
Drug Profiles 26
(fluticasone propionate + salmeterol xinafoate) - Drug Profile 26
Product Description 26
Mechanism Of Action 26
R&D Progress 26
pasireotide ER - Drug Profile 28
Product Description 28
Mechanism Of Action 28
R&D Progress 28
Synthetic Peptides for Graves' Orbitopathy - Drug Profile 31
Product Description 31
Mechanism Of Action 31
R&D Progress 31
....

Browse Complete Report with TOC @
http://www.marketresearchreportstore.com/shop/graves-ophthalmopathy-pipeline-review-h2-2016

Ask a sample and any further questions, please feel free to contact us:
Tel: +00-1-626-3463946 - U.S
Email: [email protected]
Web: http://www.marketresearchreportstore.com/

About Market Research Report Store
Since the establishment, Market Research Report Store has determined to take the online market research reports platform to the next level. With our passion and profession, we are designed to be the best among the bests.
Market Research Report Store is one of the most fast-growing and professional online platforms for industry reports, market reports, and professional surveys. Our collection covers more than 100 global markets. We have cooperated with leading publishers and consultant companies to offer the best market intelligence products to our clients with instant access to our database.